A5013978185- Cardiac Valve Diseases and Treatments
- Infective Endocarditis Diagnosis and Management
- Aortic Disease and Treatment Approaches
- Cardiovascular Function and Risk Factors
- Cardiac Imaging and Diagnostics
- Atrial Fibrillation Management and Outcomes
- Coronary Interventions and Diagnostics
- Dementia and Cognitive Impairment Research
- Cardiac pacing and defibrillation studies
- Pulmonary Hypertension Research and Treatments
- Cardiac Structural Anomalies and Repair
- Antiplatelet Therapy and Cardiovascular Diseases
- Venous Thromboembolism Diagnosis and Management
- Cardiovascular Issues in Pregnancy
- Cardiovascular Disease and Adiposity
- Neurological Disease Mechanisms and Treatments
- Cardiac Arrhythmias and Treatments
- Renin-Angiotensin System Studies
- Psychotherapy Techniques and Applications
- Aortic Thrombus and Embolism
- Gout, Hyperuricemia, Uric Acid
- Cardiac and Coronary Surgery Techniques
- Artificial Intelligence in Healthcare and Education
- Prenatal Screening and Diagnostics
- Healthcare Decision-Making and Restraints
Second Affiliated Hospital of Zhejiang University
2016-2025
Zhejiang University
2016-2025
Zhejiang Center for Disease Control and Prevention
2025
Wannan Medical College
2024
First Affiliated Hospital of Wannan Medical College
2024
First Affiliated Hospital of Hebei Medical University
2014-2023
Hebei Medical University
2012-2023
Max Delbrück Center
2019
Zhejiang Chinese Medical University
2016
Massachusetts Department of Mental Health
2014
Abstract Objectives To explore assessment of supra‐annular structure for self‐expanding transcatheter heart valve (THV) size selection in patients with bicuspid aortic stenosis (AS). Background Annulus‐based device from CT measurement is the standard sizing strategy tricuspid before replacement (TAVR). Because deformity, AS has not been systemically studied. Methods Twelve who underwent TAVR THVs were included this study. assess structure, sequential balloon valvuloplasty was performed every...
Transcatheter aortic valve implantation (TAVI) might be a feasible treatment option for more patients with bicuspid (BAV) stenosis. However, long-term follow-up data in this population are scarce.The aim of study was to evaluate three-year outcomes after TAVI BAV.A total 246 consecutive who underwent at single centre China between March 2013 and February 2018 were enrolled study. Clinical outcomes, health status echocardiography followed recorded three years.Among 109 (44.3%) BAV patients,...
An increasing number of bicuspid aortic valve (BAV) patients are undergoing transcatheter replacement (TAVR), but the risk brain injury in diffusion-weighted magnetic resonance imaging (DW-MRI) is currently unknown.This study sought to evaluate BAV following TAVR.A total 204 consecutive severe stenosis who underwent TAVR were enrolled. A 83 (40.7%) patients, and other 121 tricuspid (TAV) patients. All received DW-MRI at baseline, after TAVR.Median ages (76 years [interquartile range (IQR):...
<title>Abstract</title> Background The Double Perclose ProGlide™ (Abbott Vascular Devices) is widely adopted device for closing the main arterial access in transfemoral transcatheter aortic valve replacement (TF-TAVR),. Prior studies have compared single versus double approach, but yielding controversial results, highlighting a gap clinical randomized controlled trials. Trial design This an investigator-initiated, open-label, multicenter, trial designed to compare outcomes of closure...
Few centers routinely report aortic arch calcification (AAC) due to the lack of an easy and effective evaluation method. The association between AAC clinical prognosis patients who undergo transcatheter valve replacement (TAVR) is unclear. We aimed develop a rapid method evaluate in underwent TAVR further assess their prognosis. enrolled 464 consecutive with stenosis TAVR. Patients severe (11.2%), moderate (18.5%), mild (58.2%), no (12.1%) had estimated 3-year all-cause mortality incidence...
Transcatheter aortic valve replacement (TAVR) has become the standard treatment for severe stenosis and shown comparable efficacy to traditional surgery in low intermediate-risk patients. However, bioprosthetic valves used TAVR have a limited lifespan, failure, including calcification, rupture or infection may develop, leading poor clinical outcomes. Elevated blood pressure been identified as key factor its role failure is gaining increasing attention. Hypertension accelerate calcification...
Objective: To investigate the feasibility of transcatheter edge-to-edge repair (TEER) using a short-clip strategy for patients with moderate-to-severe or greater degenerative mitral regurgitation caused by commissural prolapse. Methods: This retrospective study included severe secondary to prolapse who underwent TEER at Second Affiliated Hospital Zhejiang University School Medicine between September 2022 and July 2024. Preoperative clinical imaging data, intraoperative details, procedural...
<b><i>Background:</i></b> Mild cognitive impairment (MCI) has been suggested as a term for boundary area between normal aging and dementia. This study was designed to determine the prevalence of MCI in elderly Hebei province, China, explore its related factors. <b><i>Methods:</i></b> Participants included 2,601 community-dwelling people aged 60 years or older who resided four major cities province. In stage 1 study, Mini-Mental State...
<b><i>Aims:</i></b> Permanent pacemaker (PPM) implantation is one of the most common complications after transcatheter aortic valve replacement (TAVR). We studied incidence PPM and identified predictors in patients who underwent TAVR a Chinese population. <b><i>Methods Results:</i></b> A total 256 with self-expandable valves were included. The our study population was 14.8%. In received implantation, proportion bicuspid (BAV) much lower...
The staging classification of aortic stenosis (AS) which characterises the extent cardiac damage has been validated in patients undergoing transcatheter valve implantation (TAVI). Short-term changes after TAVI and their association with long-term prognosis remain unknown.
Abstract Objectives We aimed to validate a novel staging system for aortic stenosis (AS) in Chinese patient cohort undergoing transcatheter valve replacement (TAVR), and compare this classification the traditional Society of Thoracic Surgeons (STS) score TAVR risk stratification. Background A AS based on extent cardiac damage upon echocardiography was recently proposed. Methods Patients were prospectively enrolled into Transcatheter Aortic Valve Replacement Single Center Registry Population...
BACKGROUND: Current data is lacking about the progression of ascending aortic dilatation after transcatheter valve replacement (TAVR) in stenosis (AS) patients with bicuspid (BAV) and tricuspid (TAV).This study aims to assess rate (mm/ year) TAVR BAV versus TAV using a multidetector computed tomography (MDCT) follow-up determine predictors rate.METHODS: Severe AS undergoing from March 2013 2018 at our center MDCT follow-ups were included.BAV identifi ed baseline MDCT.Baseline images...
Background: Patient-specific computer simulation of transcatheter aortic valve replacement (TAVR) can provide unique insights in device-patient interaction. Aims: This study was to compare sealing behavior patients with bicuspid valves (BAV) and tricuspid (TAV) through patient-specific computational modeling. Methods: retrospectively performed FEops HEARTguide for TAVR patients. Simulation output compared postprocedural computed tomography echocardiography validate the accuracy. Skirt...